The facility will enable more sustainable,
cost-effective, and high-performing EV batteries
The Chemours Company (Chemours) (NYSE: CC), a global leader in
delivering innovative performance chemistry, today announced the
opening of the Chemours Battery Innovation Center (CBIC), a
first-in-its-class laboratory facility located at the Chemours
Discovery Hub in Newark, Delaware. A multi-million-dollar
investment, the CBIC supports the testing and scaling of next
generation battery technologies, to enable more sustainable,
cost-effective, energy-efficient, and high-performing batteries for
hybrid and electric vehicles (EVs).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240813311055/en/
Chemours opens state-of-the-art Battery
Innovation Center at its Chemours Discovery Hub in Newark, Del.
(From left to right): Chemours President & CEO Denise Dignam,
U.S. Senator Chris Coons (Del.), Chemours – Advanced Performance
Materials President Gerardo Familiar. (Photo: Business Wire)
“Chemours has a rich history of using our unmatched knowledge of
chemistry to develop innovations that help solve our customers'
biggest challenges,” said Denise Dignam, President and Chief
Executive Officer at Chemours. “The Chemours Battery Innovation
Center is a state-of-the-art lab and investment in the long-term
potential of improving the sustainability footprint and performance
of hybrid and electric vehicle batteries. We are committed to
supporting the electrification of the automotive industry through
collaboration and putting our team’s deep technical expertise to
work.”
“Delaware is on the cutting-edge of technology worldwide thanks
in large part to investments like this, where Chemours has turned
to the workforce around Newark to launch their state-of-the-art
laboratory facility,” said Senator Chris Coons of Delaware. “I’m
all charged up to see Delaware lead the way in battery innovations
that will bring about a cleaner future.”
“Innovation is the Delaware way, and that’s exactly what we’re
celebrating today,” said Representative Lisa Blunt Rochester,
member of the House Energy and Commerce Committee. “Through this
new, state-of-the-art Battery Innovation Center, Chemours is
helping propel us closer toward actualizing a clean energy future
for all.”
The CBIC leverages Chemours’ application development expertise
to drive innovation in partnership with customers to scale
production of more sustainable, high-performance lithium-ion
batteries (LiBs). The facility will serve as a technical support
lab for partners and customers to collaborate with Chemours’
engineers to iterate, pilot, and adopt novel approaches to
fabricating cost-effective LiBs.
“Electric vehicles are an essential part of the clean energy
transition, and Chemours is dedicated to applying our advanced
chemistry and material science knowledge to accelerate the electric
future,” said Gerardo Familiar, President of Advanced Performance
Materials at Chemours. “For example, our Teflon™ fluoropolymer
binders are vital in developing solvent-free battery electrode
manufacturing, which unlocks the path for more cost-effective and
energy-efficient vehicles. Through the Chemours Battery Innovation
Center, we can enable the adoption and scalability of this novel
dry electrode coating technology to advance the capabilities of
LiBs and the electric vehicle industry.”
The CBIC’s state-of-the-art equipment and data analytics
capabilities enable predictive modeling to help EV manufacturers
adopt this novel battery manufacturing technology to make
better-performing EVs a reality.
About The Chemours Company The Chemours Company (NYSE:
CC) is a global leader in providing industrial and specialty
chemicals products for markets, including coatings, plastics,
refrigeration and air conditioning, transportation, semiconductor
and advanced electronics, general industrial, and oil and gas.
Through our three businesses – Titanium Technologies, Thermal &
Specialized Solutions, and Advanced Performance Materials – we
deliver application expertise and chemistry-based innovations that
solve customers’ biggest challenges. Our flagship products are sold
under prominent brands such as Ti-Pure™, Opteon™, Freon™, Nafion™,
Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware
and listed on the NYSE under the symbol CC, Chemours has
approximately 6,100 employees and 28 manufacturing sites, and
serves approximately 2,700 customers in approximately 110
countries.
For more information, visit chemours.com or follow us on X
(formerly Twitter) @Chemours or LinkedIn.
Forward-Looking Statements This press release contains
forward-looking statements, within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, which involve risks and uncertainties.
Forward-looking statements provide current expectations of future
events based on certain assumptions and include any statement that
does not directly relate to a historical or current fact. The words
"believe," "expect," "will," "anticipate," "plan," "estimate,"
"target," "project" and similar expressions, among others,
generally identify "forward-looking statements," which speak only
as of the date such statements were made. These forward-looking
statements may address, among other things, expected contributions
to advancing the performance of electric vehicles batteries,
improving sustainability, plans to continue investment in research
and development, all of which are subject to substantial risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. These
statements are not guarantees of future performance.
Forward-looking statements also involve risks and uncertainties
that are beyond Chemours' control. Matters outside our control,
including general economic conditions, geopolitical conditions and
global health events, and changes in environmental regulations in
the U.S. or other jurisdictions that affect demand for or adoption
of our products, have affected or may affect our business and
operations and may or may continue to hinder our ability to provide
goods and services to customers, cause disruptions in our supply
chains such as through strikes, labor disruptions or other events,
adversely affect our business partners, significantly reduce the
demand for our products, adversely affect the health and welfare of
our personnel or cause other unpredictable events. Additionally,
there may be other risks and uncertainties that Chemours is unable
to identify at this time or that Chemours does not currently expect
to have a material impact on its business. Factors that could cause
or contribute to these differences include the risks, uncertainties
and other factors discussed in our filings with the U.S. Securities
and Exchange Commission, including in our Annual Report on Form
10-K for the year ended December 31, 2023 and our Quarterly Report
on Form 10-Q for the quarter ended June 30, 2024. Chemours assumes
no obligation to revise or update any forward-looking statement for
any reason, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240813311055/en/
INVESTORS Brandon Ontjes Vice President, Investor
Relations +1.302.773.3300 investor@chemours.com
Kurt Bonner, Manager, Investor Relations +1.302.773.0026
investor@chemours.com
NEWS MEDIA Cassie Olszewski Corporate Media & Brand
Reputation Leader +1.302.219.7140 media@chemours.com
Chemours (NYSE:CC)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Chemours (NYSE:CC)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
